Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Gasoline Fund Lp
UGA
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
Taysha Gene Therapies (TSHA)
- 4.420
- -0.070-1.56%
Close Apr 13 16:00 ET
- 4.480
- +0.060+1.36%
Post 19:08 ET
1.27BMarket Cap-13.00P/E (TTM)
4.565High4.365Low1.58MVolume4.490Open4.490Prev Close7.03MTurnover0.80%Turnover RatioLossP/E (Static)287.27MShares6.02052wk High5.14P/B876.46MFloat Cap1.22052wk Low--Dividend TTM198.29MShs Float33.350Historical High--Div Yield TTM4.45%Range %0.500Historical Low4.436Avg Price1Lot Size
Taysha Gene Therapies (TSHA) Key Financial Indicators
TSHA Earnings per Share (EPS)
According to the latest financial report of Taysha Gene Therapies, the latest earnings per share (TTM) for the company is -0.08. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
TSHA Free Cash Flow (FCF)
Interested in knowing about Taysha Gene Therapies's free cash flow? The latest report shows it as -26.97M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
TSHA Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Taysha Gene Therapies shows that the company's current ratio is 12.23, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
TSHA Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Taysha Gene Therapies, the quick ratio is 12.04, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
TSHA Return on Equity (ROE)
Want to learn more about the financial health of Taysha Gene Therapies? The latest ROE figure is -11.96%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
TSHA Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Taysha Gene Therapies, the total asset return on investment (ROA) is -8.44%.
Currency: USD
Quarterly
Loading...
TSHA Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Taysha Gene Therapies's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
TSHA Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Taysha Gene Therapies, the net profit margin is -507.77%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
At 22:00 Beijing time on April 13, the US Central Command officially blocked maritime traffic at Iranian ports, imposing the strictest sanct
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm